| Name | Title | Contact Details |
|---|
Depuy is engaged in the development, manufacture and sale of orthopaedic joint implants (primarily hips, knees and shoulders), spinal implants, related surgical instruments, trauma products and sports medicine soft goods. (Source: 10-K)
Excedrin is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Anthem, Inc., is a provider of health insurance in the United States.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Mercy Retirement and Care Center, a nonprofit organization, has been providing quality compassionate care and services to older adults for more than 130 years. Supportive residential, assisted living, dementia care and skilled nursing programs are offered